About Nanosphere
Nanosphere develops, manufactures and markets an advanced molecular diagnostic platform, the Verigene System, which enables simple, cost-effective, and highly sensitive nucleic acid (DNA and RNA) and protein testing on a single platform.
Our breakthrough technology helps hospitals improve patient care and lowers costs by providing time-critical information, allowing earlier detection of disease and more targeted treatment. Our products have the potential to:
Empower physicians to better manage infectious diseases through timely and clinically actionable diagnostic information;
Enable earlier detection of life-threatening disease through ultra sensitive protein tests, while advancing the viability and clinical significance of new and existing biomarkers;
Improve patient outcomes and reduce medical costs through point-of-care pharmacogenetic tests.
The Verigene System is differentiated by its ease of use, rapid turnaround times and ability to detect many targets on a single test, referred to as multiplexing. We are developing, completing clinical trials, and commercializing a broad menu of tests.
- Focus : Manufacturer
- Industry : Diagnostics
Here you will find Nanosphere, Inc.
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
